Grappling with obesity and the metabolic diseases cascading from it, they are now among the plurality of Americans who have ...

The active ingredient in Wegovy goes by the chemical name semaglutide. The first place an expiring patent will allow ...

Semaglutide is a generic medication. Its brand names are approved for the treatment of type 2 diabetes and obesity. Compounded semaglutide is not FDA-approved, could come with risks, and may ...

Researchers have watched nervously as the resulting gray market of so-called generic semaglutide has ballooned. Pharmacies are technically allowed to make their own versions of brand-name drugs ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...

We’re firmly in the “buyer beware” era of obesity drugs. And unfortunately, it seems like we’re going to be stuck here for a ...

Swiss pharmaceutical company Sandoz is launching a generic semaglutide, the main ingredient of Ozempic, in the U.S. when the market opens in 2030, Bloomberg reported Sept. 3. The company first ...

Sun Pharma of India and Mylan Pharmaceuticals of West Virginia seek FDA approval of generic versions of the popular ...